| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/09/2014 | US20140011838 Compositions and methods for treating warts associated with viral infections |
| 01/09/2014 | US20140011837 Compositions and methods for treating warts associated with viral infections |
| 01/09/2014 | US20140011834 Stable formulations, and methods of their preparation and use |
| 01/09/2014 | US20140011832 Encased Tamper Resistant Controlled Release Dosage Forms |
| 01/09/2014 | US20140011831 Use of opioid antagonists |
| 01/09/2014 | US20140011830 Artemisinin-Based Combination Therapy For Treating Parasitic Mediated Disease |
| 01/09/2014 | US20140011829 Artemisinin-Based Combination Therapy For Treating Viral Mediated Disease |
| 01/09/2014 | US20140011826 Metabotropic glutamate receptor group i antagonists for treatment of abnormal union of tissue |
| 01/09/2014 | US20140011825 Compounds and Compositions as Protein Kinase Inhibitors |
| 01/09/2014 | US20140011822 Methods and materials for reducing venous stenosis formation of an arteriovenous fistula or graft |
| 01/09/2014 | US20140011821 Egfr mutations |
| 01/09/2014 | US20140011820 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia |
| 01/09/2014 | US20140011819 Novel selective pi3k delta inhibitors |
| 01/09/2014 | US20140011817 Composition for reducing nervous system injury and method of making and use thereof |
| 01/09/2014 | US20140011815 Fitness assay and associated methods |
| 01/09/2014 | US20140011812 Methods of Treating Inflammation |
| 01/09/2014 | US20140011809 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 01/09/2014 | US20140011802 Fused Aminodihydrothiazine Derivatives |
| 01/09/2014 | US20140011801 Heteroaryl quinazoline derivatives |
| 01/09/2014 | US20140011798 Imidazopyrrolidinone compounds |
| 01/09/2014 | US20140011797 Use of immunosuppressant compounds in a new indication |
| 01/09/2014 | US20140011794 Substituted porphyrins |
| 01/09/2014 | US20140011791 Myelin regeneration with androgens |
| 01/09/2014 | US20140011790 Methods and materials for reducing supression of immune function |
| 01/09/2014 | US20140011789 Pharmaceutical delivery systems for hydrophobic drugs and compositions compositions comprising same |
| 01/09/2014 | US20140011788 Pharmaceutical composition and method for treating hypogonadism |
| 01/09/2014 | US20140011787 Androgen treatment in females |
| 01/09/2014 | US20140011784 Method and composition for treating asthma |
| 01/09/2014 | US20140011783 Organic compounds |
| 01/09/2014 | US20140011782 Drug combinations for the treatment of duchenne muscular dystrophy |
| 01/09/2014 | US20140011781 Method for treating or preventing anemia using testis extract as active ingredient |
| 01/09/2014 | US20140011780 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
| 01/09/2014 | US20140011775 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 01/09/2014 | US20140011774 Selective androgen receptor modulators |
| 01/09/2014 | US20140011772 Compositions and methods for treating conditions associated with neuronal dysfunction |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140011769 Methods of Treating Retroviral Infections and Related Dosage Regimes |
| 01/09/2014 | US20140011764 Anti-Viral Pyrimidine Nucleoside Analogues |
| 01/09/2014 | US20140011761 Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis |
| 01/09/2014 | US20140011759 Compositions and methods of treatment of drug resistant cancers |
| 01/09/2014 | US20140011758 Isoxazoline derivatives as antiparasitic agents |
| 01/09/2014 | US20140011756 Method for Treatment of Inflammation |
| 01/09/2014 | US20140011755 Cardiac Glycosides for Treating Autoimmune Disease |
| 01/09/2014 | US20140011754 Crystalline form of benzylbenzene sglt2 inhibitor |
| 01/09/2014 | US20140011749 Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients |
| 01/09/2014 | US20140011745 Organ preconditioning, arrest, protection, preservation and recovery (2) |
| 01/09/2014 | US20140011244 Method for Producing Probiotically Derived Compounds |
| 01/09/2014 | US20140011181 Organ arrest, protection, preservation and recovery |
| 01/09/2014 | US20140010903 Curcuminoid composition with enhanced bioavailability and a process for its preparation |
| 01/09/2014 | US20140010902 Excipient system for topical delivery of pharmaceutical agents |
| 01/09/2014 | US20140010901 Bleomycin hydrolase production promotor |
| 01/09/2014 | US20140010898 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/09/2014 | US20140010897 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/09/2014 | US20140010895 Colonoscopy - preparation |
| 01/09/2014 | US20140010894 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 01/09/2014 | US20140010893 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | US20140010889 Krill oil and carotenoid composition, associated method and delivery system |
| 01/09/2014 | US20140010888 Bioeffective krill oil compositions |
| 01/09/2014 | US20140010887 Modified starch material of biocompatible hemostasis |
| 01/09/2014 | US20140010884 Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans |
| 01/09/2014 | US20140010883 Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor |
| 01/09/2014 | US20140010882 Pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide |
| 01/09/2014 | US20140010878 Pharmaceutical compositions containing flibanserin |
| 01/09/2014 | US20140010877 Phosphate-binding magnesium salts and uses thereof |
| 01/09/2014 | US20140010876 Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamide |
| 01/09/2014 | US20140010875 Encased Tamper Resistant Controlled Release Dosage Forms |
| 01/09/2014 | US20140010873 Abuse deterrent pharmaceutical compositions for controlled release |
| 01/09/2014 | US20140010872 Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor |
| 01/09/2014 | US20140010870 Pharmaceutical formulation comprising inositol |
| 01/09/2014 | US20140010869 Formulation and manufacturing process for calcium acetate capsules |
| 01/09/2014 | US20140010868 Krill oil and carotenoid composition, associated method and delivery system |
| 01/09/2014 | US20140010867 Treatment of proliferative disorders with a chemiluminescent agent |
| 01/09/2014 | US20140010866 Methods and systems for treatment of migraines and other indications |
| 01/09/2014 | US20140010865 Enhanced immune response in bovine species |
| 01/09/2014 | US20140010862 Multifunctional biodegradable peg nanocarrier-based hydrogels for preventing hiv transmission |
| 01/09/2014 | US20140010859 Barley protein microcapsules |
| 01/09/2014 | US20140010847 Materials for treating and preventing mucosa related disease |
| 01/09/2014 | US20140010830 Non-Coding Immunomodulatory DNA Construct |
| 01/09/2014 | US20140010826 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System |
| 01/09/2014 | US20140010823 Method for determining optimum intraocular locations for drug delivery systems |
| 01/09/2014 | US20140010821 Use of CD83 in combination therapies |
| 01/09/2014 | US20140010806 Treatment of Ocular Diseases |
| 01/09/2014 | US20140010805 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| 01/09/2014 | US20140010804 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 01/09/2014 | US20140010801 Compositions and Methods for Restoring or Rejuvenating Stem/Progenitor Cell Function |
| 01/09/2014 | US20140010796 Application Methods to Rapidly Alter Disease and Injury States Using Molecular Transport of B6 |
| 01/09/2014 | US20140010795 Formulation and method for the prevention and treatment of bone metastases or other bone diseases |
| 01/09/2014 | US20140010791 Methods for regulating protein function in cells in vivo using synthetic small molecules |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | US20140010783 Antiviral compounds |
| 01/09/2014 | US20140010781 Sirna against cbl-b and optionally il-2 and il-12 for use in the treatment of cancer |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010777 Methods for determining personalized treatment compositions for prostate cancer and breast cancer |
| 01/09/2014 | US20140010773 Use of n-(4-methoxyphenyl)-1-phenyl-1h-pyrazol-3-amine and related compounds |
| 01/09/2014 | US20140010771 Allantoin-Containing Skin Cream |
| 01/09/2014 | US20140010758 Peptidomimetic inhibitors of psma |
| 01/09/2014 | US20140007865 Olopatadine nasal spray regimen for children |
| 01/09/2014 | DE102012211807A1 Wirkstoffkombinationen aus Magnolienrindenextrakt und Hyaluronsäure und ihre kosmetische und/oder dermatologische Verwendung Active compound combinations of magnolia bark extract and hyaluronic acid and its cosmetic and / or dermatological use |